ENDRA LIFE SCIENCES INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
ENDRA LIFE SCIENCES INC. (NDRA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $6.20 trillion for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2024-03-28
- ENDRA LIFE SCIENCES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $6.20T.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2022-12-31 | $6.20T 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |